NIAID Banner Logo Image

Other Viruses Citation List: July 20 - August 2, 2012

Epstein-Barr Virus

1. Small Molecule and Peptide-Mediated Inhibition of Epstein-Barr Virus Nuclear Antigen 1 Dimerization. Kim, S.Y., K.A. Song, E. Kieff, and M.S. Kang. Biochemical and Biophysical Research Communications, 2012. 424(2): p. 251-256; PMID[22735264].

[PubMed]. OV_0720-080212.

Hepatitis B Virus

2. Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation. Cai, D., C. Mills, W. Yu, R. Yan, C.E. Aldrich, J.R. Saputelli, W.S. Mason, X. Xu, J.T. Guo, T.M. Block, A. Cuconati, and H. Guo. Antimicrobial Agents and Chemotherapy, 2012. 56(8): p. 4277-4288; PMID[22644022].

[PubMed]. OV_0720-080212.

3. Mulberrofuran G and Isomulberrofuran G from Morus Alba L.: Anti-Hepatitis B Virus Activity and Mass Spectrometric Fragmentation. Geng, C., Y.B. Ma, X.M. Zhang, S.Y. Yao, D.Q. Xue, P.R. Zhang, and J.J. Chen. Journal of Agricultural and Food Chemistry, 2012; PMID[22835135].

[PubMed]. OV_0720-080212.

4. Effect of Interferon-gamma and Tumor Necrosis Factor-alpha on Hepatitis B Virus Following Lamivudine Treatment. Shi, H., L. Lu, N.P. Zhang, S.C. Zhang, and X.Z. Shen. World Journal of Gastroenterology, 2012. 18(27): p. 3617-3622; PMID[22826629].

[PubMed]. OV_0720-080212.

5. Lamivudine Plus Adefovir vs. Entecavir in HBeAg-Positive Hepatitis B with Sequential Treatment Failure of Lamivudine and Adefovir. Son, C.Y., H.J. Ryu, J.M. Lee, S.H. Ahn, Y. Kim do, M.H. Lee, K.H. Han, C.Y. Chon, and J.Y. Park. Liver International, 2012. 32(7): p. 1179-1185; PMID[22452737].

[PubMed]. OV_0720-080212.

6. Design, Synthesis, and Molecular Hybrids of Caudatin and Cinnamic Acids as Novel Anti-Hepatitis B Virus Agents. Wang, L.J., C.A. Geng, Y.B. Ma, J. Luo, X.Y. Huang, H. Chen, N.J. Zhou, X.M. Zhang, and J.J. Chen. European Journal of Medicinal Chemistry, 2012. 54: p. 352-365; PMID[22687441]. [PubMed]. OV_0720-080212.

Hepatitis C Virus

7. LET-7B Is a Novel Regulator of Hepatitis C Virus Replication. Cheng, J.C., Y.J. Yeh, C.P. Tseng, S.D. Hsu, Y.L. Chang, N. Sakamoto, and H.D. Huang. Cellular and Molecular Life Sciences, 2012. 69(15): p. 2621-2633; PMID[22391672].

[PubMed]. OV_0720-080212.

8. Synthesis and Antiviral Properties of Novel 7-Heterocyclic Substituted 7-Deaza-adenine Nucleoside Inhibitors of Hepatitis C NS5B Polymerase. Di Francesco, M.E., S. Avolio, M. Pompei, S. Pesci, E. Monteagudo, V. Pucci, C. Giuliano, F. Fiore, M. Rowley, and V. Summa. Bioorganic Medicinal Chemistry, 2012. 20(15): p. 4801-4811; PMID[22770556].

[PubMed]. OV_0720-080212.

9. Anti-HCV Activity and Toxicity of Pi4KIIIbeta Inhibitors. Lamarche, M.J., J. Borawski, A. Bose, C. Capacci-Daniel, R. Colvin, M. Dennehy, J. Ding, M. Dobler, J. Drumm, L.A. Gaither, J. Gao, X. Jiang, K. Lin, U. McKeever, X. Puyang, P. Raman, S. Thohan, R. Tommasi, K. Wagner, X. Xiong, T. Zabawa, S. Zhu, and B. Wiedmann. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]. PMID[22825118].

[PubMed]. OV_0720-080212.

10. Discovery of Substituted N-Phenylbenzenesulphonamides as a Novel Class of Non-Nucleoside Hepatitis C Virus Polymerase Inhibitors. May, M.M., D. Brohm, A. Harrenga, T. Marquardt, B. Riedl, J. Kreuter, H. Zimmermann, H. Ruebsamen-Schaeff, and A. Urban. Antiviral Research, 2012. 95(2): p. 182-191; PMID[22580131].

[PubMed]. OV_0720-080212.

11. Discovery of ITX 4520: A Highly Potent Orally Bioavailable Hepatitis C Virus Entry Inhibitor. Mittapalli, G.K., F. Zhao, A. Jackson, H. Gao, H. Lee, S. Chow, M.P. Kaur, N. Nguyen, R. Zamboni, J. McKelvy, F. Wong-Staal, and J.E. Macdonald. Bioorganic and Medicinal Chemistry Letters, 2012. 22(15): p. 4955-4961; PMID[22784640].

[PubMed]. OV_0720-080212.

12. Anti-Retroviral Drugs Do Not Facilitate Hepatitis C Virus (HCV) Infection in Vitro. Sandmann, L., M. Wilson, D. Back, H. Wedemeyer, M.P. Manns, E. Steinmann, T. Pietschmann, T.V. Hahn, and S. Ciesek. Antiviral Research, 2012. [Epub ahead of print]. PMID[22842003].

[PubMed]. OV_0720-080212.

13. MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4A Protease with Broad Activity Across Genotypes and Resistant Variants. Summa, V., S.W. Ludmerer, J.A. McCauley, C. Fandozzi, C. Burlein, G. Claudio, P.J. Coleman, J.M. Dimuzio, M. Ferrara, M. Di Filippo, A.T. Gates, D.J. Graham, S. Harper, D.J. Hazuda, C. McHale, E. Monteagudo, V. Pucci, M. Rowley, M.T. Rudd, A. Soriano, M.W. Stahlhut, J.P. Vacca, D.B. Olsen, N.J. Liverton, and S.S. Carroll. Antimicrobial Agents and Chemotherapy, 2012. 56(8): p. 4161-4167; PMID[22615282].

[PubMed]. OV_0720-080212.

14. Tegobuvir (GS-9190) Potency Against HCV Chimeric Replicons Derived from Consensus NS5B Sequences from Genotypes 2b, 3a, 4a, 5a, and 6a. Wong, K.A., S. Xu, R. Martin, M.D. Miller, and H. Mo. Virology, 2012. 429(1): p. 57-62; PMID[22543048].

[PubMed]. OV_0720-080212.

Herpes Simplex Virus 1

15. In Vitro and in Vivo Evaluation of a Novel anti-Herpetic Flavonoid, 4'-Phenylflavone, and its Synergistic Actions with Acyclovir. Hayashi, K., M. Iinuma, K. Sasaki, and T. Hayashi. Archives of Virology, 2012. 157(8): p. 1489-1498; PMID[22580497].

[PubMed]. OV_0720-080212.

Human Cytomegalovirus

16. Synthesis and Biological Properties of C-2 Triazolylinosine Derivatives. Lakshman, M.K., A. Kumar, R. Balachandran, B.W. Day, G. Andrei, R. Snoeck, and J. Balzarini. Journal of Organic Chemistry, 2012. 77(14): p. 5870-83; PMID[22758929].

[PubMed]. OV_0720-080212.

17. Human Mannose-Binding Lectin Inhibits Human Cytomegalovirus Infection in Human Embryonic Pulmonary Fibroblast. Wu, W., Y. Chen, H. Qiao, R. Tao, W. Gu, and S. Shang. APMIS, 2012. 120(8): p. 675-682; PMID[22779691].

[PubMed]. OV_0720-080212.

Citations from the ISI Web of Knowledge Listings for O.V.

18. Isoflavone Agonists of IRF-3 Dependent Signaling Have Antiviral Activity against RNA Viruses. Bedard, K.M., M.L. Wang, S.C. Proll, Y.M. Loo, M.G. Katze, M. Gale, and S.P. Iadonato. Journal of Virology, 2012. 86(13): p. 7334-7344; ISI[000305501600031].

[WOS]. OV_0720-080212.

19. (-)-Epigallocatechin-3-gallate Inhibits the Replication Cycle of Hepatitis C Virus. Chen, C., H. Qiu, J. Gong, Q. Liu, H. Xiao, X.W. Chen, B.L. Sun, and R.G. Yang. Archives of Virology, 2012. 157(7): p. 1301-1312; ISI[000305795300009].

[WOS]. OV_0720-080212.

20. UNC93b1 Mediates Innate Inflammation and Antiviral Defense in the Liver During Acute Murine Cytomegalovirus Infection. Crane, M.J., P.J. Gaddi, and T.P. Salazar-Mather. PLoS One, 2012. 7(6); ISI[000305583300109].

[WOS]. OV_0720-080212.

21. Artemisinin-Derived Dimer Diphenyl Phosphate is an Irreversible Inhibitor of Human Cytomegalovirus Replication. He, R., K. Park, H.Y. Cai, A. Kapoor, M. Forman, B. Mott, G.H. Posner, and R. Arav-Boger. Antimicrobial Agents and Chemotherapy, 2012. 56(7): p. 3508-3515; ISI[000305673000005]

[WOS]. OV_0720-080212.

22. The Cyclophilin Inhibitor Scy-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes. Hopkins, S., M. Bobardt, U. Chatterji, J.A. Garcia-Rivera, P. Lim, and P.A. Gallay. Antimicrobial Agents and Chemotherapy, 2012. 56(7): p. 3888-3897; ISI[000305673000056].

[WOS]. OV_0720-080212.

23. Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate. Jiang, J.Y., W. Cun, X.F. Wu, Q. Shi, H.L. Tang, and G.X. Luo. Journal of Virology, 2012. 86(13): p. 7256-7267; ISI[000305501600024].

[WOS]. OV_0720-080212.

24. A Daphnane Diterpenoid Isolated from Wikstroemia Polyantha Induces an Inflammatory Response and Modulates Mirna Activity. Khong, A., R. Forestieri, D.E. Williams, B.O. Patrick, A. Olmstead, V. Svinti, E. Schaeffer, F. Jean, M. Roberge, R.J. Andersen, and E. Jan. PLoS One, 2012. 7(6); ISI[000305808700039].

[WOS]. OV_0720-080212.

25. Hepatoprotective and Anti-Hepatitis C Viral Activity of Platycodon Grandiflorum Extract on Carbon Tetrachloride-Induced Acute Hepatic Injury in Mice. Kim, T.W., J.H. Lim, I.B. Song, S.J. Park, J.W. Yang, J.C. Shin, J.W. Suh, H.Y. Son, E.S. Cho, M.S. Kim, S.W. Lee, J.W. Kim, and H.I. Yun. Journal of Nutritional Science and Vitaminology, 2012. 58(3): p. 187-194; ISI[000306025300006].

[WOS]. OV_0720-080212.

26. Screening and Mechanism of Trapping Ligand Antagonist Peptide for Chemokine Receptor US28 of Human Cytomegalovirus. Liu, H.G., H.X. Sun, L. Li, X.M. Mo, X.Y. Li, and G. Zhang. Tropical Journal of Pharmaceutical Research, 2012. 11(2): p. 193-200; ISI[000305738800004].

[WOS]. OV_0720-080212.

27. Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase. Shiryaev, S.A., A.V. Cheltsov, and A.Y. Strongin. PLoS One, 2012. 7(7); PMID[WOS:000305966500040].

[WOS]. OV_0720-080212.

28. Simple and Accurate Approaches to Predict the Activity of Benzothiadiazine Derivatives as HCV Inhibitors. Su, L., L. Li, Y.W. Li, X.Y. Zhang, X.Y. Huang, and H.L. Zhai. Medicinal Chemistry Research, 2012. 21(8): p. 2079-2096; PMID[WOS:000305559900061].

[WOS]. OV_0720-080212.

29. 5-Acetyl-2-Arylbenzimidazoles as Antiviral Agents. Part 4. Vitale, G., P. Corona, M. Loriga, A. Carta, G. Paglietti, G. Giliberti, G. Sanna, P. Farci, M.E. Marongiu, and P. La Colla. European Journal of Medicinal Chemistry, 2012. 53: p. 83-97; PMID[WOS:000305863100009].

[WOS]. OV_0720-080212.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022